These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Phenytoin-induced gingival overgrowth: a community-based cross-sectional study in Ferrara, Italy. Casetta I; Granieri E; Desiderá M; Monetti VC; Tola MR; Paolino E; Govoni V; Calura G Neuroepidemiology; 1997; 16(6):296-303. PubMed ID: 9430129 [TBL] [Abstract][Full Text] [Related]
23. Phenytoin-induced depression of salivary IgA and gingival hyperplasia. Aarli JA Epilepsia; 1976 Sep; 17(3):283-91. PubMed ID: 976219 [TBL] [Abstract][Full Text] [Related]
24. The effect of a plaque control program on the development of phenytoin-induced gingival overgrowth. A 2-year longitudinal study. Dahllöf G; Modéer T J Clin Periodontol; 1986 Oct; 13(9):845-9. PubMed ID: 3465754 [TBL] [Abstract][Full Text] [Related]
25. Phenytoin-induced gingival enlargement: a dental awakening for patients with epilepsy. Mohan RP; Rastogi K; Bhushan R; Verma S BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23616318 [TBL] [Abstract][Full Text] [Related]
26. [Association between phenytoin-induced gingival hyperplasia and periodontopathic bacteria in institutionalized patients with severe motor and intellectual disabilities]. Miyazaki H Kokubyo Gakkai Zasshi; 2010 Jun; 77(2):140-8. PubMed ID: 20662307 [TBL] [Abstract][Full Text] [Related]
27. [Histopathology of gingival manifestations of hydantoin therapy]. Hanzély B Fogorv Sz; 1976; 69 Suppl():418-20. PubMed ID: 1071997 [No Abstract] [Full Text] [Related]
29. Salivary composition, phenytoin ingestion and gingival overgrowth. Smith QT; Hamilton MJ J Periodontol; 1981 Nov; 52(11):673-9. PubMed ID: 6946208 [TBL] [Abstract][Full Text] [Related]
30. Plasma and gingival crevicular fluid phenytoin concentrations as risk factors for gingival overgrowth. Güncü GN; Caglayan F; Dinçel A; Bozkurt A; Saygi S; Karabulut E J Periodontol; 2006 Dec; 77(12):2005-10. PubMed ID: 17209785 [TBL] [Abstract][Full Text] [Related]
31. Prevalence and risk of gingival enlargement in patients treated with anticonvulsant drugs. Brunet L; Miranda J; Roset P; Berini L; Farré M; Mendieta C Eur J Clin Invest; 2001 Sep; 31(9):781-8. PubMed ID: 11589720 [TBL] [Abstract][Full Text] [Related]
32. Serum phenytoin concentration and IgG antibody titre to periodontal bacteria in patients with phenytoin-induced gingival overgrowth. Yamada H; Nishimura F; Furuno K; Naruishi K; Kobayashi Y; Takashiba S; Murayama Y J Int Acad Periodontol; 2001 Apr; 3(2):42-7. PubMed ID: 12666977 [TBL] [Abstract][Full Text] [Related]
33. [Histopathological study on diphenylhydantoin gingival hyperplasia in rats, especially the role of gingival inflammation in diphenylhydantoin gingival hyperplasia]. Watanabe H Nihon Shishubyo Gakkai Kaishi; 1982 Sep; 24(3):385-408. PubMed ID: 6962259 [No Abstract] [Full Text] [Related]
34. The effect of multiple anticonvulsant therapy on the expression of phenytoin-induced gingival overgrowth. Kamali F; McLaughlin WS; Ball DE; Seymour RA J Clin Periodontol; 1999 Dec; 26(12):802-5. PubMed ID: 10599907 [TBL] [Abstract][Full Text] [Related]
35. The effects of phenytoin and sodium valproate on the periodontal health of adult epileptic patients. Seymour RA; Smith DG; Turnbull DN J Clin Periodontol; 1985 Jul; 12(6):413-9. PubMed ID: 3926831 [TBL] [Abstract][Full Text] [Related]
36. Folic acid and phenytoin induced gingival overgrowth--is there a preventive effect. Prasad VN; Chawla HS; Goyal A; Gauba K; Singhi P J Indian Soc Pedod Prev Dent; 2004 Jun; 22(2):82-91. PubMed ID: 15491092 [TBL] [Abstract][Full Text] [Related]
37. The effect of oral physiotherapy on dilantin gingival hyperplasia. King DA; Hawes RR; Bibby BG J Oral Pathol; 1976 Jan; 5(1):1-7. PubMed ID: 814217 [TBL] [Abstract][Full Text] [Related]
38. [Ultrastructural study on phenytoin-induced gingival proliferation]. Meng HX Zhonghua Yi Xue Za Zhi; 1988 Jan; 68(1):31-2, 3. PubMed ID: 3133090 [No Abstract] [Full Text] [Related]
39. Diphenylhydantoin-induced gingival hyperplasia: its relationship to dose and serum level. Kapur RN; Girgis S; Little TM; Masotti RE Dev Med Child Neurol; 1973 Aug; 15(4):483-7. PubMed ID: 4732898 [No Abstract] [Full Text] [Related]
40. [Application of drug monitoring with saliva--the influence of phenytoin upon the salivary inorganic constituents]. Watanabe S; Igarashi S; Ichida T Rinsho Byori; 1986 Mar; 34(3):254-61. PubMed ID: 3712786 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]